Pharmaceuticals

Competitor Analysis Mergers & Acquisitions AI Applications Patient Rights Company Analysis Drug Pricing Respiratory Syncytial Virus Medicare Healthcare Companies Insurance Companies

9 ARTICLES

3d ago

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Expected to close in the third quarter of 2025, the deal secures Lilly’s control of VERVE-102, a Fast Track–designated gene-editing therapy in Phase 1b trials.

4 ARTICLES

4d ago

AMD Shares Surge on Next-Gen MI400 AI Chips and Helios Server Rack

9 ARTICLES

2w ago

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

13 ARTICLES

2w ago

S&P 500 and Nasdaq Log Biggest Monthly Rally Since 2023, But Tariff Risks Persist

5 ARTICLES

4w ago

Emcure Pharmaceuticals Reports 64% Profit Surge, Shares Hit Upper Circuit

11 ARTICLES

4w ago

Sun Pharma Shares Drop 5% Following Mixed Q4 FY25 Results

5 ARTICLES

4w ago

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

3 ARTICLES

4w ago

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

4 ARTICLES

4w ago

Mankind Pharma Posts Profit Decline but Outperforms Estimates with Strong Revenue Growth

8 ARTICLES

4w ago

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

3 ARTICLES

4w ago

Pfizer Reports 85% Profit Surge, Shares Climb 12% on Strong Q4 FY25 Results

31 ARTICLES

4w ago

Novo Nordisk CEO Steps Down Following Share Price Collapse

14 ARTICLES

last mo.

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

9 ARTICLES

last mo.

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

6 ARTICLES

last mo.

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

10 ARTICLES

last mo.

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

6 ARTICLES

last mo.

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

Particle.news

Pharmaceuticals

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

AMD Shares Surge on Next-Gen MI400 AI Chips and Helios Server Rack

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

S&P 500 and Nasdaq Log Biggest Monthly Rally Since 2023, But Tariff Risks Persist

Emcure Pharmaceuticals Reports 64% Profit Surge, Shares Hit Upper Circuit

Sun Pharma Shares Drop 5% Following Mixed Q4 FY25 Results

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

Mankind Pharma Posts Profit Decline but Outperforms Estimates with Strong Revenue Growth

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Never miss stories about

Pharmaceuticals

Pfizer Reports 85% Profit Surge, Shares Climb 12% on Strong Q4 FY25 Results

Novo Nordisk CEO Steps Down Following Share Price Collapse

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Hims & Hers Reports Record Q1 Results While Stock Dips on Cautious Q2 Guidance

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

CVS Health Beats Q1 Expectations and Raises 2025 Earnings Guidance

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

Never miss stories about

Pharmaceuticals